These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37095619)

  • 1. The Cancer/Testis Antigen CT45A1 Promotes Transcription of Oncogenic
    Yang P; Qiao Y; Liao H; Huang Y; Meng M; Chen Y; Zhou Q
    J Breast Cancer; 2023 Apr; 26(2):168-185. PubMed ID: 37095619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer/testis-45A1 promotes cervical cancer cell tumorigenesis and drug resistance by activating oncogenic SRC and downstream signaling pathways.
    Meng M; Guo Y; Chen Y; Li X; Zhang B; Xie Z; Liu J; Zhao Z; Liu Y; Zhang T; Qiao Y; Shang B; Zhou Q
    Cell Oncol (Dordr); 2024 Apr; 47(2):657-676. PubMed ID: 37924456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CT45A1 acts as a new proto-oncogene to trigger tumorigenesis and cancer metastasis.
    Shang B; Gao A; Pan Y; Zhang G; Tu J; Zhou Y; Yang P; Cao Z; Wei Q; Ding Y; Zhang J; Zhao Y; Zhou Q
    Cell Death Dis; 2014 Jun; 5(6):e1285. PubMed ID: 24901056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The extracellular sulfatase SULF2 promotes liver tumorigenesis by stimulating assembly of a promoter-looping GLI1-STAT3 transcriptional complex.
    Carr RM; Romecin Duran PA; Tolosa EJ; Ma C; Oseini AM; Moser CD; Banini BA; Huang J; Asumda F; Dhanasekaran R; Graham RP; Toruner MD; Safgren SL; Almada LL; Wang S; Patnaik MM; Roberts LR; Fernandez-Zapico ME
    J Biol Chem; 2020 Feb; 295(9):2698-2712. PubMed ID: 31988246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulfatase-2 promotes the growth and metastasis of colorectal cancer by activating Akt and Erk1/2 pathways.
    Tao Y; Han T; Zhang T; Sun C
    Biomed Pharmacother; 2017 May; 89():1370-1377. PubMed ID: 28320104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-422a functions as a tumor suppressor in non-small cell lung cancer through SULF2-mediated TGF-β/SMAD signaling pathway.
    Li WQ; Zhang JP; Wang YY; Li XZ; Sun L
    Cell Cycle; 2019 Aug; 18(15):1727-1744. PubMed ID: 31204561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CT45A1 promotes the metastasis of osteosarcoma cells in vitro and in vivo through β-catenin.
    Wen M; Ren H; Zhang S; Li T; Zhang J; Ren P
    Cell Death Dis; 2021 Jun; 12(7):650. PubMed ID: 34172717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulfatase 2 protects hepatocellular carcinoma cells against apoptosis induced by the PI3K inhibitor LY294002 and ERK and JNK kinase inhibitors.
    Lai JP; Sandhu DS; Yu C; Moser CD; Hu C; Shire AM; Aderca I; Murphy LM; Adjei AA; Sanderson S; Roberts LR
    Liver Int; 2010 Nov; 30(10):1522-8. PubMed ID: 21040406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CT45A1 siRNA silencing suppresses the proliferation, metastasis and invasion of lung cancer cells by downregulating the ERK/CREB signaling pathway.
    Tang F; Tang S; Guo X; Yang C; Jia K
    Mol Med Rep; 2017 Nov; 16(5):6708-6714. PubMed ID: 28901509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The oncogenic effect of sulfatase 2 in human hepatocellular carcinoma is mediated in part by glypican 3-dependent Wnt activation.
    Lai JP; Oseini AM; Moser CD; Yu C; Elsawa SF; Hu C; Nakamura I; Han T; Aderca I; Isomoto H; Garrity-Park MM; Shire AM; Li J; Sanderson SO; Adjei AA; Fernandez-Zapico ME; Roberts LR
    Hepatology; 2010 Nov; 52(5):1680-9. PubMed ID: 20725905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The human sulfatase 2 inhibitor 2,4-disulfonylphenyl-tert-butylnitrone (OKN-007) has an antitumor effect in hepatocellular carcinoma mediated via suppression of TGFB1/SMAD2 and Hedgehog/GLI1 signaling.
    Zheng X; Gai X; Han S; Moser CD; Hu C; Shire AM; Floyd RA; Roberts LR
    Genes Chromosomes Cancer; 2013 Mar; 52(3):225-36. PubMed ID: 23109092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. JMJD2A-dependent silencing of Sp1 in advanced breast cancer promotes metastasis by downregulation of DIRAS3.
    Li L; Gao P; Li Y; Shen Y; Xie J; Sun D; Xue A; Zhao Z; Xu Z; Zhang M; Li B; Jiang J
    Breast Cancer Res Treat; 2014 Oct; 147(3):487-500. PubMed ID: 25193278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulfatase 2 up-regulates glypican 3, promotes fibroblast growth factor signaling, and decreases survival in hepatocellular carcinoma.
    Lai JP; Sandhu DS; Yu C; Han T; Moser CD; Jackson KK; Guerrero RB; Aderca I; Isomoto H; Garrity-Park MM; Zou H; Shire AM; Nagorney DM; Sanderson SO; Adjei AA; Lee JS; Thorgeirsson SS; Roberts LR
    Hepatology; 2008 Apr; 47(4):1211-22. PubMed ID: 18318435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulfatase 2 promotes breast cancer progression through regulating some tumor-related factors.
    Zhu C; He L; Zhou X; Nie X; Gu Y
    Oncol Rep; 2016 Mar; 35(3):1318-28. PubMed ID: 26708018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SULF2 promotes tumorigenesis and inhibits apoptosis of cervical cancer cells through the ERK/AKT signaling pathway.
    Jiang T; Chen ZH; Chen Z; Tan D
    Braz J Med Biol Res; 2020; 53(2):e8901. PubMed ID: 32049100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcription factor SP1-induced microRNA-146b-3p facilitates the progression and metastasis of colorectal cancer via regulating FAM107A.
    Wang D; Feng M; Ma X; Tao K; Wang G
    Life Sci; 2021 Jul; 277():119398. PubMed ID: 33831429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulfatase-2 from Cancer Associated Fibroblasts: An Environmental Target for Hepatocellular Carcinoma?
    Zaki MYW; Alhasan SF; Shukla R; McCain M; Laszczewska M; Geh D; Patman GL; Televantou D; Whitehead A; Maurício JP; Barksby B; Gee LM; Paish HL; Leslie J; Younes R; Burt AD; Borthwick LA; Thomas H; Beale GS; Govaere O; Sia D; Anstee QM; Tiniakos D; Oakley F; Reeves HL
    Liver Cancer; 2022 Dec; 11(6):540-557. PubMed ID: 36589727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-527 inhibits TGF-β/SMAD induced epithelial-mesenchymal transition via downregulating SULF2 expression in non-small-cell lung cancer.
    Huo W; Zhu XM; Pan XY; Du M; Sun Z; Li ZM
    Math Biosci Eng; 2019 May; 16(5):4607-4621. PubMed ID: 31499680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sp1 contributes to overexpression of stanniocalcin 2 through regulation of promoter activity in colon adenocarcinoma.
    Li JB; Liu ZX; Zhang R; Ma SP; Lin T; Li YX; Yang SH; Zhang WC; Wang YP
    World J Gastroenterol; 2019 Jun; 25(22):2776-2787. PubMed ID: 31236000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The oncoprotein HBXIP up-regulates FGF4 through activating transcriptional factor Sp1 to promote the migration of breast cancer cells.
    Shi H; Li Y; Feng G; Li L; Fang R; Wang Z; Qu J; Ding P; Zhang X; Ye L
    Biochem Biophys Res Commun; 2016 Feb; 471(1):89-94. PubMed ID: 26828265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.